The 12th Annual Phacilitate Leaders’ Forum brings historical west and east coast conferences together for one exciting event. The result is a unique blend of specific therapeutic area coverage combined with overall strategic research and development insight from pharma and biotech decision makers, as well as key external stakeholders. In addition to plenary sessions, the conference will include three individual forums related to Metabolic, Oncology, and Autoimmune and Inflammation topics.
Chief Medical Officer J. Michael O’Neal, MD will speak as part of the Oncology Forum on October 16th at 3:30pm. His topic is The Role of Imaging in Drug Development - A Changing Paradigm.
Senior Vice President of Medical Affairs Colin G. Miller, Ph.D. F.I.C.R, CSci, will speak as part of the Metabolic Forum on October 17th at 3:20pm. His topic is Safety End Points on Skeletal Integrity in Metabolic Diseases: Learnings from Rosiglitazone and Canagliflozin.
BioClinica is a Gold Sponsor of this event and will have representatives available to discuss the company’s Medical Imaging and Cardiac Safety Solutions.